Edition:
United States

Puma Biotechnology Inc (PBYI.OQ)

PBYI.OQ on NASDAQ Stock Exchange Global Select Market

25.47USD
17 Jan 2019
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$25.47
Open
$25.11
Day's High
$25.61
Day's Low
$24.73
Volume
294,014
Avg. Vol
371,128
52-wk High
$95.00
52-wk Low
$17.62

Chart for

About

Puma Biotechnology, Inc. is a biopharmaceutical company that focuses on the development and commercialization of products for the treatment of cancer. The Company focuses on in-licensing the development and commercialization rights to over three drug candidates, including PB272 (neratinib (oral)), PB272 (neratinib (intravenous))... (more)

Overall

Beta: 0.85
Market Cap(Mil.): $4,516.76
Shares Outstanding(Mil.): 37.21
Dividend: --
Yield (%): --

Financials

  PBYI.OQ Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -8.14 -- --
ROI: -224.57 8.99 14.48
ROE: -233.95 10.13 15.99

BRIEF-Oncbiomune Announces Former Puma Biotechnology Executive And Genentech Veteran Brian Barnett, M.D., As Chief Executive Officer

* ONCBIOMUNE ANNOUNCES FORMER PUMA BIOTECHNOLOGY EXECUTIVE AND GENENTECH VETERAN BRIAN BARNETT, M.D., AS CHIEF EXECUTIVE OFFICER Source text for Eikon: Further company coverage:

Jan 09 2019

Earnings vs. Estimates